Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease

Active 0 6 17 23 B-chronic_disease
peptic 7 13 24 30 I-chronic_disease
ulcer 14 19 31 36 I-chronic_disease

Anticipation 0 12 37 49 O
of 13 15 50 52 O
the 16 19 53 56 O
need 20 24 57 61 O
for 25 28 62 65 O
major 29 34 66 71 O
elective 35 43 72 80 O
surgery 44 51 81 88 B-treatment
during 52 58 89 95 O
the 59 62 96 99 O
course 63 69 100 106 O
of 70 72 107 109 O
the 73 76 110 113 O
study 77 82 114 119 O
treatment 83 92 120 129 B-treatment

Any 0 3 130 133 O
disease 4 11 134 141 O
or 12 14 142 144 O
condition 15 24 145 154 O
that 25 29 155 159 O
contraindicates 30 45 160 175 O
the 46 49 176 179 O
use 50 53 180 183 O
of 54 56 184 186 O
the 57 60 187 190 O
study 61 66 191 196 O
medication 67 77 197 207 B-treatment
/ 77 78 207 208 O
treatment 78 87 208 217 B-treatment
or 88 90 218 220 O
places 91 97 221 227 O
the 98 101 228 231 O
patient 102 109 232 239 O
at 110 112 240 242 O
an 113 115 243 245 O
unacceptable 116 128 246 258 O
risk 129 133 259 263 O
of 134 136 264 266 O
experiencing 137 149 267 279 O
treatment 150 159 280 289 O
- 159 160 289 290 O
related 160 167 290 297 O
complications 168 181 298 311 O

Any 0 3 312 315 O
significant 4 15 316 327 O
cardiovascular 16 30 328 342 B-chronic_disease
disease 31 38 343 350 I-chronic_disease
not 39 42 351 354 O
controled 43 52 355 364 O
by 53 55 365 367 O
standard 56 64 368 376 O
therapy 65 72 377 384 B-treatment
e.g. 73 77 385 389 O
systemic 78 86 390 398 B-chronic_disease
hypertension 87 99 399 411 I-chronic_disease

Conventional 0 12 412 424 B-treatment
chemotherapy 13 25 425 437 I-treatment
, 25 26 437 438 O
antiangiogenic 27 41 439 453 B-treatment
treatment 42 51 454 463 I-treatment
or 52 54 464 466 O
complete 55 63 467 475 B-treatment
irradiation 64 75 476 487 I-treatment
of 76 78 488 490 O
all 79 82 491 494 O
disease 83 90 495 502 O
for 91 94 503 506 O
current 95 102 507 514 O
relapse 103 110 515 522 O
( 111 112 523 524 O
surgery 112 119 524 531 B-treatment
may 120 123 532 535 O
be 124 126 536 538 O
performed 127 136 539 548 O
before 137 143 549 555 O
antiangiogenic 144 158 556 570 O
treatment 159 168 571 580 O
; 168 169 580 581 O
patients 170 178 582 590 O
with 179 183 591 595 O
sites 184 189 596 601 O
of 190 192 602 604 O
disease 193 200 605 612 O
not 201 204 613 616 O
irradiated 205 215 617 627 O
are 216 219 628 631 O
still 220 225 632 637 O
eligible 226 234 638 646 O
for 235 238 647 650 O
the 239 242 651 654 O
protocol 243 251 655 663 O
) 251 252 663 664 O

Female 0 6 665 671 B-gender

Histological 0 12 672 684 O
confirmation 13 25 685 697 O
of 26 28 698 700 O
medulloblastoma 29 44 701 716 B-cancer
at 45 47 717 719 O
diagnosis 48 57 720 729 O
or 58 60 730 732 O
relapse 61 68 733 740 O

Karnofsky 0 9 741 750 B-clinical_variable
performance 10 21 751 762 I-clinical_variable
status 22 28 763 769 I-clinical_variable
≥50 29 32 770 773 O
. 32 33 773 774 O
For 34 37 775 778 O
infants 38 45 779 786 O
and 46 49 787 790 O
children 50 58 791 799 O
less 59 63 800 804 O
than 64 68 805 809 O
12 69 71 810 812 B-upper_bound
years 72 77 813 818 I-upper_bound
of 78 80 819 821 O
age 81 84 822 825 B-age
, 84 85 825 826 O
the 86 89 827 830 O
Lansky 90 96 831 837 B-clinical_variable
play 97 101 838 842 I-clinical_variable
scale 102 107 843 848 I-clinical_variable
≥50 108 111 849 852 O
% 111 112 852 853 I-lower_bound
will 113 117 854 858 O
be 118 120 859 861 O
used 121 125 862 866 O

Known 0 5 867 872 O
hypersensitivity 6 22 873 889 O
to 23 25 890 892 O
any 26 29 893 896 B-allergy_name
of 30 32 897 899 I-allergy_name
the 33 36 900 903 I-allergy_name
drugs 37 42 904 909 I-allergy_name
in 43 45 910 912 I-allergy_name
the 46 49 913 916 I-allergy_name
protocol 50 58 917 925 I-allergy_name

Participants 0 12 926 938 O
must 13 17 939 943 O
have 18 22 944 948 O
normal 23 29 949 955 O
organ 30 35 956 961 O
and 36 39 962 965 O
bone 40 44 966 970 O
marrow 45 51 971 977 O
function 52 60 978 986 O
( 61 62 987 988 O
ALT 62 65 988 991 B-clinical_variable
< 66 67 992 993 O
5x 67 69 993 995 B-upper_bound
institutional 70 83 996 1009 I-upper_bound
upper 84 89 1010 1015 I-upper_bound
limit 90 95 1016 1021 I-upper_bound
of 96 98 1022 1024 I-upper_bound
normal 99 105 1025 1031 I-upper_bound
, 105 106 1031 1032 O
creatinine 107 117 1033 1043 B-clinical_variable
< 118 119 1044 1045 O
1.5x 119 123 1045 1049 B-upper_bound
institutional 124 137 1050 1063 I-upper_bound
upper 138 143 1064 1069 I-upper_bound
limit 144 149 1070 1075 I-upper_bound
of 150 152 1076 1078 I-upper_bound
normal 153 159 1079 1085 I-upper_bound
for 160 163 1086 1089 O
age 164 167 1090 1093 B-age
, 167 168 1093 1094 O
WBC 169 172 1095 1098 B-clinical_variable
> 173 174 1099 1100 O
1000 174 178 1100 1104 B-lower_bound
/ 178 179 1104 1105 I-lower_bound
mm3 179 182 1105 1108 I-lower_bound
, 182 183 1108 1109 O
platelets 184 193 1110 1119 B-clinical_variable
> 194 195 1120 1121 O
20,000 196 202 1122 1128 B-lower_bound
/ 202 203 1128 1129 I-lower_bound
mm3 203 206 1129 1132 I-lower_bound
. 206 207 1132 1133 O
Patients 208 216 1134 1142 O
with 217 221 1143 1147 O
values 222 228 1148 1154 O
less 229 233 1155 1159 O
than 234 238 1160 1164 O
WBC 239 242 1165 1168 O
2000 243 247 1169 1173 B-upper_bound
/ 247 248 1173 1174 I-upper_bound
mm3 248 251 1174 1177 I-upper_bound
or 252 254 1178 1180 O
platelets 255 264 1181 1190 O
50,000 265 271 1191 1197 O
/ 271 272 1197 1198 O
mm3 272 275 1198 1201 O
will 276 280 1202 1206 O
require 281 288 1207 1214 O
initiation 289 299 1215 1225 O
of 300 302 1226 1228 O
treatment 303 312 1229 1238 B-treatment
with 313 317 1239 1243 O
etoposide 318 327 1244 1253 B-treatment
and 328 331 1254 1257 O
cyclophosphamide 332 348 1258 1274 B-treatment
at 349 351 1275 1277 O
a 352 353 1278 1279 O
lower 354 359 1280 1285 O
starting 360 368 1286 1294 O
dose 369 373 1295 1299 O
as 374 376 1300 1302 O
defined 377 384 1303 1310 O
within 385 391 1311 1317 O
the 392 395 1318 1321 O
protocol 396 404 1322 1330 O

Pregnancy 0 9 1331 1340 B-pregnancy

Relapsed 0 8 1341 1349 O
or 9 11 1350 1352 O
progressive 12 23 1353 1364 O
medulloblastoma 24 39 1365 1380 B-cancer
( 40 41 1381 1382 O
at 41 43 1382 1384 O
least 44 49 1385 1390 O
one 50 53 1391 1394 B-lower_bound
site 54 58 1395 1399 O
of 59 61 1400 1402 O
untreated 62 71 1403 1412 O
recurrent 72 81 1413 1422 O
disease 82 89 1423 1430 O
) 89 90 1430 1431 O

VP 0 2 1432 1434 B-treatment
- 2 3 1434 1435 I-treatment
shunt 3 8 1435 1440 I-treatment
dependency 9 19 1441 1451 O

aged 0 4 1452 1456 B-age
from 5 9 1457 1461 O
0 10 11 1462 1463 B-lower_bound
to 12 14 1464 1466 O
< 15 16 1467 1468 O
20 16 18 1468 1470 B-upper_bound
years 19 24 1471 1476 I-upper_bound
( 25 26 1477 1478 O
at 26 28 1478 1480 O
time 29 33 1481 1485 O
of 34 36 1486 1488 O
original 37 45 1489 1497 O
diagnosis 46 55 1498 1507 O
) 55 56 1507 1508 O

male 0 4 1509 1513 B-gender

